Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets
暂无分享,去创建一个
Gary Longton | Patricia L. Blount | P. Blount | B. Reid | P. Rabinovitch | D. Levine | G. Longton | Peter S Rabinovitch | Brian J Reid | Douglas S Levine | Patricia L Blount
[1] R. Sampliner,et al. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. , 1996, Gastrointestinal endoscopy.
[2] J. Peters,et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. , 1994, The Journal of thoracic and cardiovascular surgery.
[3] C. McConkey,et al. The rising trend in oesophageal adenocarcinoma and gastric cardia. , 1992, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[4] W S Payne,et al. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. , 1985, The New England journal of medicine.
[5] H. Joensuu,et al. Autolysis is a potential source of false aneuploid peaks in flow cytometric DNA histograms. , 1989, Cytometry.
[6] A R Zinsmeister,et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. , 1997, Gastroenterology.
[7] B. Reid,et al. Barrett's esophagus and esophageal adenocarcinoma. , 1991, Gastroenterology clinics of North America.
[8] R. Sampliner,et al. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus , 1998, American Journal of Gastroenterology.
[9] O. Cummings,et al. Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice. , 1999, Gastrointestinal endoscopy.
[10] B. Reid,et al. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. , 1987, Gastroenterology.
[11] P. Rabinovitch. DNA content histogram and cell-cycle analysis. , 1994, Methods in cell biology.
[12] R. Goyal,et al. Prevalence of metaplasia at the gastro-oesophageal junction , 1994, The Lancet.
[13] E. Achkar,et al. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. , 1988, The American journal of gastroenterology.
[14] N. Walker,et al. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. , 1991, Gut.
[15] R. Sampliner,et al. Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus. , 1989, Gastroenterology.
[16] B. Reid,et al. Progression to cancer in Barrett's esophagus is associated with genomic instability. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[17] N. Shaheen,et al. Surveillance for Barrett's esophagus: are we saving lives? , 1997, Gastroenterology.
[18] A. Cameron. Barrett's esophagus: does the incidence of adenocarcinoma matter? , 1997, The American journal of gastroenterology.
[19] J. Mayberry,et al. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus , 1988, The British journal of surgery.
[20] C. Cox,et al. Guidelines for implementation of clinical DNA cytometry. International Society for Analytical Cytology. , 1993, Cytometry.
[21] B. Reid,et al. Endoscopic Diagnosis of Esophageal Neoplasms , 1992 .
[22] R. Sampliner,et al. Flow cytometry in Barrett's esophagus: when all is said and done, more is said than done! , 1993, American Journal of Gastroenterology.
[23] C. Begg,et al. Impact of hospital volume on operative mortality for major cancer surgery. , 1998, JAMA.
[24] R Montironi,et al. Interlaboratory reproducibility of semiautomated cell cycle analysis of flow cytometry DNA-histograms obtained from fresh material of 1,295 breast cancer cases. , 1996, Human pathology.
[25] J. G. van den Tweel,et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. , 1989, Gastroenterology.
[26] J. V. van Lanschot,et al. Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation , 1998, The Journal of pathology.
[27] W. Hop,et al. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. , 1995, Gut.
[28] R. Sampliner,et al. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. , 1997, The American journal of gastroenterology.
[29] W G Doos,et al. Adenocarcinoma and Barrett's esophagus. An overrated risk? , 1984, Gastroenterology.
[30] B. Overholt,et al. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. , 1999, Gastrointestinal endoscopy.
[31] R. Haggitt,et al. Barrett's esophagus, dysplasia, and adenocarcinoma. , 1994, Human pathology.
[32] J. Fraumeni,et al. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.
[33] G. Mazzini,et al. Quality control study of the Italian Group of Cytometry on flow cytometry DNA content measurements: II. Factors affecting inter- and intralaboratory variability. , 1997, Cytometry.
[34] Patricia L. Blount,et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. , 1993, Gastroenterology.
[35] Dawn Provenzale,et al. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk , 1999, American Journal of Gastroenterology.
[36] P. Blount,et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. , 1992, Gastroenterology.
[37] G. Falk,et al. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: Report on the cleveland clinic barrett's esophagus registry , 1999, American Journal of Gastroenterology.
[38] F. Ellis,et al. Barrett's esophagus. Prevalence and incidence of adenocarcinoma. , 1991, Archives of internal medicine.
[39] J. Jass,et al. Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Observer variation and correlations. , 1988, Gastroenterology.
[40] J. Coon,et al. Interlaboratory variation in DNA flow cytometry. Results of the College of American Pathologists' Survey. , 1994, Archives of pathology & laboratory medicine.
[41] P. Aló,et al. DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett's esophagus: thirteen-year follow-up study on a cohort of patients. , 1998, Cytometry.
[42] G Van Belle,et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.